RMEI header logo


Online Activities


A Systematic, Patient-Centered Approach to Managing Metastatic Gastric or GEJ Adenocarcinoma

Targeted therapies and new approaches to immunotherapy are changing the treatment of metastatic gastric and gastroesophageal (GEJ) cancer. Biomarker testing and rational sequencing are essential for optimal treatment selection and outcomes. To ensure that treatment choices coincide with patient preferences, goals, and expectations, it is essential to involve patients via shared decision making.